{
  "id": "mhgap#screening_cues_fc73e00c",
  "content": "Module and Recommendation\nrecommendation\nStrength of the recommendation and certainty of the evidence\nnumber\nDepression (DEP)\nDEP1 (update) In adults with moderate-to-severe depression, citalopram, escitalopram, fluoxetine,\nfluvoxamine, paroxetine or sertraline (SSRIs) or amitriptyline (TCA) should be considered.\nConditional recommendation. Very low certainty of evidence.\nDEP2 (update) In adults with moderate-to-severe depression who have benefited from initial\nantidepressant treatment, continuation of the antidepressant treatment should be\nconsidered for at least six months after remission. Treatment should be regularly\nmonitored, with special attention to treatment adherence, change in depressive\nsymptoms and possible adverse effects.\nConditional recommendation. Very low certainty of evidence.\nDEP3 (update) Structured psychological interventions should be offered for the treatment of adults\nwith moderate-to-severe depression, namely behavioural activation therapy (BAT), brief\npsychodynamic therapy (DYN), cognitive behavioural therapy (CBT), interpersonal therapy\n(IPT), problem-solving therapy (PST) and third wave therapies (3WV).\nStrong recommendation. Moderate certainty of evidence.\nDEP4 (update) In adults with moderate-to-severe depression, psychological interventions or combined\ntreatment should be considered based on individual preferences and careful consideration\nof the balance of benefits and harms. Antidepressant medicine alone for adults with\ndepression (moderate to severe) should only be considered when psychological",
  "metadata": {
    "source": "WHO mhGAP-IG 2023",
    "url": "https://www.who.int/",
    "condition": "General",
    "risk_band": "low",
    "topics": [
      "screening_cues",
      "referral",
      "management"
    ],
    "is_clinical": true,
    "is_advice": false
  },
  "index_text": "General — Screening Cues Module and Recommendation\nrecommendation\nStrength of the recommendation and certainty of the evidence\nnumber\nDepression (DEP)\nDEP1 (update) In adults with moderate-to-severe depression, citalopram, escitalopram, fluoxetine,\nfluvoxamine, paroxetine or sertraline (SSRIs) or amitriptyline (TCA) should be considered.\nConditional recommendation. Very low certainty of evidence.\nDEP2 (update) In adults with moderate-to-severe depression who have benefited from initial\nantidepressant treatment, continuation of the antidepressant treatment should be\nconsidered for at least six months after remission. Treatment should be regularly\nmonitored, with special attention to treatment adherence, change in depressive\nsymptoms and possible adverse effects.\nConditional recommendation. Very low certainty of evidence.\nDEP3 (update) Structured psychological interventions should be offered for the treatment of adults\nwith moderate-to-severe depression, namely behavioural activation therapy (BAT), brief\npsychodynamic therapy (DYN), cognitive behavioural therapy (CBT), interpersonal therapy\n(IPT), problem-solving therapy (PST) and third wave therapies (3WV).\nStrong recommendation. Moderate certainty of evidence.\nDEP4 (update) In adults with moderate-to-severe depression, psychological interventions or combined\ntreatment should be considered based on individual preferences and careful consideration\nof the balance of benefits and harms. Antidepressant medicine alone for adults with\ndepression (moderate to severe) should only be considered when psychological Module and recommendation\nrecommendation\nstrength of the recommendation and certainty of the evidence\nnumber\ntrầm cảm (dep)\ndep1 (update) in adults with moderate-to-severe trầm cảm, citalopram, escitalopram, fluoxetine,\n..."
}